DK426083A - Pteriner, fremgangsmaader til deres fremstilling samt deres anvendelse - Google Patents

Pteriner, fremgangsmaader til deres fremstilling samt deres anvendelse Download PDF

Info

Publication number
DK426083A
DK426083A DK426083A DK426083A DK426083A DK 426083 A DK426083 A DK 426083A DK 426083 A DK426083 A DK 426083A DK 426083 A DK426083 A DK 426083A DK 426083 A DK426083 A DK 426083A
Authority
DK
Denmark
Prior art keywords
pterines
procedures
preparation
Prior art date
Application number
DK426083A
Other languages
Danish (da)
English (en)
Other versions
DK426083D0 (da
Inventor
Charles Adam Nichol
Jr John Frederick Reinhard
Cary Keith Smith
Eric Cleveland Bigham
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838318833A external-priority patent/GB8318833D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK426083D0 publication Critical patent/DK426083D0/da
Publication of DK426083A publication Critical patent/DK426083A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/06Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK426083A 1982-09-20 1983-09-19 Pteriner, fremgangsmaader til deres fremstilling samt deres anvendelse DK426083A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8226688 1982-09-20
GB838318833A GB8318833D0 (en) 1983-07-12 1983-07-12 Chemical compounds

Publications (2)

Publication Number Publication Date
DK426083D0 DK426083D0 (da) 1983-09-19
DK426083A true DK426083A (da) 1984-03-21

Family

ID=26283872

Family Applications (1)

Application Number Title Priority Date Filing Date
DK426083A DK426083A (da) 1982-09-20 1983-09-19 Pteriner, fremgangsmaader til deres fremstilling samt deres anvendelse

Country Status (5)

Country Link
EP (1) EP0108890B1 (fr)
AU (1) AU572792B2 (fr)
CA (1) CA1288099C (fr)
DE (1) DE3378634D1 (fr)
DK (1) DK426083A (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196533A (en) * 1983-04-11 1993-03-23 South Alabama Medical Science Foundation, Usa Cyclization of 5 amino-pyrimidines to quinoid 6,6 disubstituted dihydropteridines
JPS61277618A (ja) * 1985-06-04 1986-12-08 Suntory Ltd 自閉症治療剤
US5198547A (en) * 1992-03-16 1993-03-30 South Alabama Medical Science Foundation, Usa Process for N5-formylating tetrahydropteridines
EP0674627A1 (fr) * 1992-12-18 1995-10-04 The Wellcome Foundation Limited Derives de pyrimidine, de pyridine, de pteridinone et d'indazole utilises comme inhibiteurs enzymatiques
GB9226377D0 (en) * 1992-12-18 1993-02-10 Babbedge Rachel C Pharmaceutical compositions
DE4418096A1 (de) * 1994-05-24 1995-11-30 Cassella Ag Verwendung von Pteridin-Derivaten als Hemmstoffe der NO-Synthase
JP4306825B2 (ja) 1998-02-27 2009-08-05 アスビオファーマ株式会社 インスリン抵抗性が関与する血管機能異常を伴う疾患の予防または治療剤
US7276506B2 (en) 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
ES2229803T3 (es) * 1998-12-28 2005-04-16 4 Aza Bioscience Nv Efectos inmunosupresivos de derivados de pteridina.
AU2004291149C1 (en) * 2003-11-17 2021-01-21 Biomarin Pharmaceutical Inc. Methods and Compositions for the Treatment of Metabolic Disorders
US8003126B2 (en) 2004-11-17 2011-08-23 Biomarin Pharmaceutical Inc. Stable tablet formulation
US10144736B2 (en) 2006-07-20 2018-12-04 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
PT3321265T (pt) 2015-03-04 2020-07-07 Gilead Sciences Inc Compostos 4,6-diamino-pirido[3,2-d]pirimidina compounds e a sua utilização como moduladores de receptores do tipo toll
JP6746776B2 (ja) 2016-09-02 2020-08-26 ギリアード サイエンシーズ, インコーポレイテッド Toll様受容体調節剤化合物
ES2826748T3 (es) 2016-09-02 2021-05-19 Gilead Sciences Inc Derivados de 4,6-diamino-pirido[3,2-d]pirimidina como moduladores de receptores de tipo Toll
TW202212339A (zh) 2019-04-17 2022-04-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI751516B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202115056A (zh) 2019-06-28 2021-04-16 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1293541A (en) * 1969-03-18 1972-10-18 John Alexander Blair Folic acid derivatives
BE787236A (fr) * 1971-08-05 1973-02-05 Wellcome Found Compositions de potentialisation
JPS5883691A (ja) * 1981-11-13 1983-05-19 Kanegafuchi Chem Ind Co Ltd 1′,2′−ジアシル−(6r,s)−5,6,7,8−テトラヒドロ−l−ビオプテリンおよびその製法

Also Published As

Publication number Publication date
AU1925683A (en) 1984-03-29
DE3378634D1 (en) 1989-01-12
EP0108890A2 (fr) 1984-05-23
AU572792B2 (en) 1988-05-19
CA1288099C (fr) 1991-08-27
DK426083D0 (da) 1983-09-19
EP0108890A3 (en) 1985-10-02
EP0108890B1 (fr) 1988-12-07

Similar Documents

Publication Publication Date Title
DK310383A (da) 14-fluormorphinaner, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK120188D0 (da) Aminomethylheterocycler, fremgangsmaader til deres fremstilling samt deres anvendelse
DK186981A (da) 17-substitueret-6-desoxy-7,8-dihydro-6alfa-methylnoroxymorphon samt fremgangsmaade til fremstilling deraf
DK181983D0 (da) 1,8-naphthyridin- og 1,5,8-azanaphthyridin-derivater, fremgangsmade til deres fremstilling samt deres anvendelse
NO823374L (no) 3-oksoestra-17-acetonitril og umettede analoger, samt fremgangsmaate for deres fremstilling
DK426083A (da) Pteriner, fremgangsmaader til deres fremstilling samt deres anvendelse
DK398583D0 (da) Spergualin-beslaegtede forbindelser, fremgangsmader til fremstilling deraf samt deres anvendelse som laegemidler
DK459782A (da) Antiprotozoelle forbindelser, fremgangsmaade til deres fremstilling samt deres anvendelse
DK393382A (da) Aminoorganoaminosilaner, fremgangsmaade til fremstilling heraf samt deres anvendelse
DK162771C (da) 17-oxazolinsteroider, samt fremgangsmaade til deres fremstilling
DK544383D0 (da) Svovlholdige benzylidenderivater, fremgangsmade til deres fremstilling samt deres anvendelse
DK548086A (da) Nitroanthracycliner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK540887A (da) Iminooxazolidiner, fremgangsmaade til deres fremstilling samt anvendelse deraf
DK511782A (da) Benzylidenderivater, fremgangsmaade til deres fremstilling samt deres anvendelse
DK440688A (da) Sulfonylaminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK380787D0 (da) Decahydro-2-naphthylalkylaminer, fremgangsmaade til deres fremstilling samt deres anvendelse
DK247884D0 (da) Substituerede tetrahydrothiopyran-3,5-dion-4-carboxamider,fremgangsmaade til deres fremstilling og deres anvendelse samt mellemprodukter til fremstillingen
DK283783D0 (da) Polyprenylforbindelser, fremgangsmade til deres fremstilling samt deres anvendelse
DK329882A (da) Oxothienobenzoxepiner,fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK162049C (da) N-substituerede tetrahydrothiaziner, fremgangsmaader til disses fremstilling samt deres anvendelse som pesticider
DK508482A (da) Diphenylethere, fremgangsmaade til deres fremstilling samt deres anvendelse
DK165182A (da) L-substitueret-4-phenyl-polyhydro-pyridiner og-pyrrolidiner,fremgangsmaade til deres fremstilling samt deres anvendelse
DK544283D0 (da) Alkylerede benzylidenderivater, fremgangsmade til deres fremstilling samt deres anvendelse
DK84684A (da) Svovlholdige benzylidenderivater, fremgangsmaade til deres fremstilling samt deres anvendelse
DK134083A (da) 7-alfa-aminoacyl-3-chlorcephalosporiner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment